Preventing the cytotoxic effects of tyrosine kinase inhibitors on healthy breast cells through loading into the ferritin nanocages
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F20%3A43918634" target="_blank" >RIV/62156489:43210/20:43918634 - isvavai.cz</a>
Alternative codes found
RIV/00216305:26620/20:PU137947
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Preventing the cytotoxic effects of tyrosine kinase inhibitors on healthy breast cells through loading into the ferritin nanocages
Original language description
This study is focused on the antiproliferative effects of tyrosine kinase inhibitors (TKIs) loaded into the protein cage ferritin. Since many TKIs show high cytotoxicity not only towards their target, cancer cells, but also towards healthy surrounding tissue, the prevention of these adverse effects is of utmost importance. Development of nanocarriers with loaded active agents has been proven to help minimize this off-target cytotoxicity. It is also very suitable for poorly water soluble pharmaceuticals. In this study, we focused on targeting TKIs, insoluble agents, which target vascular endothelial growth factor. Preserved cytotoxic effect of chemotherapeutics after their loading to nanocarriers is one of the crucial point of the loading process. During nanoconstruct synthesis, effective loading of TKIs (lenvatinib, vandetanib) to the protein nanocage ferritin was essential. The aim was to prevent cytotoxicity towards healthy cells; neverthe-less, loss of cytotoxicity towards cancer cells had to be prevented. Therefore, after successful loading process of TKIs to the ferritin it was necessary to verify maintain-ing the level of their cytotoxicity towards the breast cancer cell lines T-47D (PR+, ER+, HER2-, FR+, MCF-7 (PR+, ER+, HER2-, FR-), as well as healthy breast cell line HBL-100 and blood elements. For this purpose, in vitro tests of cytotoxicity were performed, quantifying the antiproliferative effect as well as level of apoptosis after treatment of cell lines. For evaluation of nanocon-struct internalization and their colocalization inside the cell, confocal laser scanning microscopy was used. Antiproliferative effect of nanoconstructs were tested via clonogenic assay and inhibition of cell migration via wound healing assay. The synthesized targeted ferritin nanoconstructs were able to prevent the cytotoxicity of TKIs to healthy cells while maintaining the cytotoxicity to cancer cells.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/GA18-10251S" target="_blank" >GA18-10251S: Comprehensive insight into mechanisms of action and metabolism of tyrosine kinase inhibitors and a study of ways increasing their antitumor efficiency</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů